Your Edge In Biotech.

In the News

 

‘People in this industry just want to do something bigger than themselves’

Boston Business Journal, February 6, 2023

 

The Aducanumab Aftermath: The Industry

Tradeoffs, June. 25, 2021

 

Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700M

GeekWire, Oct. 23, 2020

 

Life sciences boom in South Lake Union

KUOW, Aug. 20, 2019

 

Why this cancer researcher (and survivor) is climbing Kilimanjaro to raise money to study cancer

Geek Wire, July. 6, 2019

 

Seattle’s Adaptive Biotechnologies upsizes stock offering on strong investor interest

Seattle Times, June. 29, 2019

 

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

GeekWire, Dec. 12, 2018

 

How Luke Timmerman created the top paid newsletter in biotech

The Substack Podcast, Oct. 12, 2018

 

LISTEN: Biotech’s sellers market, Sanofi’s second act, and literally climbing Mt. Everest

StatNews, Aug. 2, 2018

 

Luke Timmerman looks back on his summit of Mount Everest

Fred Hutch, June. 25, 2018

 

‘Gasping for air a lot’: Seattle man recounts quest for Everest

KOMO NEWS, June. 2, 2018

 

Seattle biotech journalist reaches summit of Mount Everest in bid to raise money for cancer research

Geekwire, May. 22, 2018

 

The tipping point on cancer treatment, from research labs to the top of Mount Everest

Geekwire, Mar. 20, 2018

 

Seattle writer raising funds for cancer research trains for Everest climb in unique way

Q13 Fox, Mar. 13, 2018

 

Luke Timmerman to scale Mount Everest for Fred Hutch research

Fred Hutch, Feb. 27, 2018

 

Kirkus Reviews listed ‘Hood: Trailblazer of the Genomics Age” as one of the 100 Best Indie Books of 2017

Kirkus Reviews, Dec. 18, 2017

 

Forbes listed ‘The Long Run’ as a podcast for health entrepreneurs

Forbes, Dec. 17, 2017

 

Seattle doctor’s radical idea saves 70,000 people a year

KUOW 94.9, Nov. 13, 2017

 

 

Biotech journalist Luke Timmerman to climb Mount Everest to raise $175k for cancer research

GeekWire, Oct. 26, 2017

 

Going for Mt. Everest: Seattle biotech journalist puts passions together

KOMO News, Oct. 27, 2017

 

 

“No Question, I’m Going Against the Grain of Consumer Expectations” – Luke Timmerman

Front Line Genomics, July. 25, 2017

 

Is There A Pickup Coming For Biotech IPOs?

WBUR 90.9 FM, July. 10, 2017

 

Timmerman Report is putting customer service at the center of its one-man news business

Nieman Lab, Jan. 9, 2017

 

What to expect from biotech in 2017

CNBC, Dec. 28, 2016

 

Seattle Genetics aims to put drug on the front line of battling cancer

The Seattle Times, Dec. 17, 2016

 

Is going solo a good idea? These journalists are giving it a try

Poynter, Apr. 11, 2016

 

On social media, Martin Shkreli’s arrest draws cheers

CBS News, Dec. 17, 2015

 

How a business journalist became his own boss

Talking Biz News, Oct. 21, 2015

 

Roundup: what are the best biotech news sources?

MIT Biotechnology Group, Sep. 25, 2015

 

The Worldview 100

Scientific American Worldview, June 24, 2015

 

The Emerging Bull Market For Digital Healthcare Journalism

Forbes, Feb. 7, 2015

 

Veteran reporter Luke Timmerman is back – and launching his own biotech news site

MedCityNews, Feb. 3, 2015

 

Not a Stenographer to Power: Luke Timmerman and the New ‘Timmerman Report’

Mendelspod podcast, Feb. 3, 2015

 

Climbing Solo: Luke Timmerman, KSJ ’06, Launches a Subscription Biotech Report

MIT Knight Science Journalism Fellowships blog, Feb. 3, 2015

 

Veteran biotech journalist Luke Timmerman launches subscription news site

Geekwire, Feb. 2, 2015